Alcon Inc. - Registered Shares

NYSE:ALC   4:00:00 PM EDT
+0.84 (+1.07%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)39.50B
Current PE115.83
Forward PE 29.87
2yr Forward PE 25.72
See more stats
Estimates Current Quarter
Revenue$2.36 Billion
Adjusted EPS$0.64
See more estimates
10-Day MA$78.76
50-Day MA$73.89
200-Day MA$68.71
See more pivots

Alcon Inc. - Registered Shares Stock, NYSE:ALC

Chemin de Blandonnet 8, Vernier, Geneva, Geneve (Geneva) 1214
Phone: +41.817.293.04.50
Number of Employees: 25178


Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.